Salivation

Salivation is an increase in saliva production perceived as a conscious wetting of the mouth or a heightened urge to swallow.

As a drug effect it is acute and dose-proportional, easing as the substance wears off, which sets it apart from any standing hypersalivation condition. It ranges from a mild background dampness that is easily ignored to a persistent pooling that becomes difficult to manage.

Salivation is an uncommon somatic effect reported across several drug classes. It is most commonly induced at moderate to high doses under psychedelics such as psilocybin mushrooms, mescaline, and 1B-LSD, and under depressants such as GHB, 1,4-butanediol, and GBL. It also appears under dissociatives such as ketamine and diphenidine, and under deliriants such as Amanita muscaria and grayanotoxin.

Salivation is felt as a persistent awareness of moisture gathering in the mouth: the tongue meets a wetter surface, swallowing becomes more frequent, and in stronger cases there is a subtle pressure beneath the jaw as the glands actively produce.

It tends to be a background sensation rather than a distressing one — present but largely passive — until the pooling becomes marked enough to require deliberate management. At higher doses, particularly under depressants and deliriants, it can grow prominent and intrusive.

Salivation arises through different pathways depending on the drug class:

• Psychedelics — serotonergic receptor activity can produce autonomic shifts that transiently elevate parasympathetic tone, promoting salivary secretion.
• Depressants — GHB and related compounds modulate GABA-B receptors; accompanying autonomic changes during onset can increase salivary output.
• Dissociatives — NMDA receptor antagonism produces broad autonomic dysregulation; increased salivation appears as one somatic expression of that disruption.
• Deliriants — Amanita muscaria and grayanotoxin act through distinct receptor mechanisms that stimulate autonomic secretory activity, including salivation.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both its likelihood and intensity across all associated classes. Set and setting play a smaller role here than for psychological effects — salivation is primarily a physiological response — though individual differences in autonomic reactivity account for much of the variation.

It is more consistently reported under depressants and deliriants than under psychedelics and dissociatives. It eases as the substance wears off and rarely persists beyond the acute window.